AM

Archana Mishra

Active Director Director DIN 08554437
DIN 08554437 First appointment Sep 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Archana Mishra

Data last updated:

Archana Mishra is a Director at Wiliance Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Wiliance Pharmaceuticals Private Limited reported revenue of ₹1.03 Cr (FY 2025).

DIN 08554437
Primary Designation Director
Industry Pharma
First Appointment 05 Sep 2019
Oldest Company Age 12 yrs
Largest company Wiliance Pharmaceuticals Private Limited · ₹1.03 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Sep 20192013₹1.03 Cr (FY 2025)Active

Board colleagues of Archana Mishra

Directorship timeline

Open interactive timeline →
Wiliance Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Archana Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Archana Mishra

Archana Mishra currently holds 1 directorship: Wiliance Pharmaceuticals Private Limited (Director, since 05 Sep 2019, revenue ₹1.03 Cr (FY 2025)).

Archana Mishra was first appointed on 05 Sep 2019 as Director at Wiliance Pharmaceuticals Private Limited.

The current boards of Archana Mishra's companies include Brijendra Kumar Nigam (Wiliance Pharmaceuticals Private Limited), Subhash Gautam (Wiliance Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available